Join Free

Research and publish the best content.

Immunology and Biotherapies

37.9K views | +0 today

Tags

# acute B-cell lymphoblastic leukaemia 1

# Adenylate Cyclase vector platform CyaA 1

# Antibody Nanoparticle Conjugates 1

# CAR 1

# complement-dependent cytotoxicity 1

# dual variable domain immunoglobulin 1

# EBV-Lymphoproliferative Disease 1

# FcγRIIB (CD32B) Antibodies 1

# HNSTD, highest non-severely toxic dose 1

# HPMA copolymers 1

# IL-1α 1

# limbal stem cell deficiency LSCD 1

# liquid chromatography/mass spectrometr 1

# Mode of Action 1

# mogamulizumab (Poteligeo®) 1

# MUC1 targeting immunotherapy 1

# neuroblastoma 1

# Site-specific, novel Antibody Platform 1

# T cells 1

# TCR 1

# tumor-infiltrating lymphocytes (TILs) 1

# tumor-specific antigens 3

##top selling prescription drug 1

#4-IBB 1

#AACR 3

#AACR 2015 3

#AbbVie 2

#Abciximab 1

#abs-dependent cellular phagocytosis 1

#Abzena 1

#Actemra 2

#activated T cells 5

#Active immunotherapy 3

#acute lymphoblastic leukemia 1

#acute lymphoblastic leukemia ALL 1

#Adalimumab 4

#Adaptimmune 1

#Adaptive immunity 1

#adaptive lymphocytes 1

#ADC 4

#Adcetris 1

#adjuvant CpG 1

#adoptive cell therapy (ACT) 2

#adoptive cellular cancer immunotherapy 2

#Adoptive immunotherapy 6

#Adoptive T cell therapy 5

#ADRs 2

#Aducanumab 1

#adult T cell leukaemia/lymphoma 1

#adult T-cell leukemia/lymphoma (ATL) 1

#Advanced therapy 2

#Affimed Therapeutics 1

#Age-related macular degeneration 1

#AIDS 1

#alemtuzumab 1

#Alirocumab 2

#ALL 1

#allergy 1

#Allogeneic drugs 1

#Allogeneic tumor vaccine 1

#Alnylam 1

#Alzheimer's Disease 1

#AMD 1

#Amgen 2

#AML 1

#amyloid beta 1

#angiogenesis 1

#ankylosing spondylitis (AS) 1

#anti cancer peptides 1

#anti-cytokine therapy 1

#anti-KIR agents 1

#antibody aggregation 1

#Antibody coupled receptors 1

#antibody development 2

#antibody drug conjugate 3

#antibody drug conjugates 16

#Antibody engineering 5

#antibody fragment 4

#Antibody Glycosylation 2

#antibody therapy 3

#antibody tumor targeting 1

#Antibody-dep- cell-mediated cytotoxicit 1

#antibody-dependent cellular cytotoxicit 1

#Antibody–drug ratio (ADR) 1

#anticancer mabs 1

#antidrug antibodies 1

#Antifrolumab 1

#antigen-binding fragment 1

#Apellis Pharma 1

#Apoptosis 1

#arGEN-X 1

#ASCO 1

#ASCO 2014 1

#ASCO 2015 2

#ASCO GU 1

#Astra Zeneca 1

#atherosclerosis 1

#autoimmune diseases 2

#Avastin 3

#B cell NHL 1

#B7-H3 1

#bavituximab 1

#Bertilimumab 1

#best selling prescription drug 1

#beta-1-adrenergic receptor (β1AR) 1

#bevacizumab 3

#Bexsero 1

#BI 655066 mab 1

#Bi specific antibodies 3

#Bi specific antibody 1

#Bi specific mab 1

#Bi-specific monoclonal antibodies 2

#billion dollar mabs 1

#Biogen Idec 1

#biogenerics 4

#biologics 1

#biomarkers 1

#biopharmaceuticals 1

#biosimilar 5

#biosimilar market 1

#Biotech industry 1

#Biotest AG 1

#bispecific antibodies 2

#bispecific T-cell engager (BiTE) mabs 2

#Bispecific T-cell engagers (BiTEs) 1

#BiTE® 1

#Blinatumomab 2

#blockbuster mabs 2

#Blood-Brain Barrier Technology 1

#BMJ 1

#BMS 2

#Boehringer Ingelheim 1

#Bone morphogenic proteins 1

#braf inhibitor 1

#braf inhibitors 1

#BRAf inhibitors resistance 1

#BRAF+MEK therapy 1

#breakthrough drug 1

#Breakthrough Therapy Designation 2

#breakthrough therapy drugs 1

#breast cancer 1

#cancer 10

#cancer drugs 2

#cancer immunotherapy 11

#cancer vaccines 5

#CAR 5

#CAR T cell immunotherapy 12

#CAR T cell therapy 5

#CAR-TCR 5

#carbohydrate recognition 1

#Castleman disease 1

#castrate resistant prostate cancer 1

#CCR4 mab 1

#CD154 1

#CD20 2

#CD20 mab 1

#CD25 1

#CD32B 1

#CD4 1

#CD4+ helper T cells 2

#CD40 1

#CD40LGVAX 1

#CD47 mab 1

#CD8 T cells 2

#Cell 1

#cell death 2

#cell free protein synthesis 1

#Celltrion Healthcare 1

#Cellular Biomedicine 1

#Certolizumab 2

#cetuximab 2

#CH3/CH2 domain 1

#Characterization 1

#checkpoint blockade 2

#checkpoint inhibitor 10

#checkpoint inhibitors 18

#chemokine ligands 2

#Chiesi 1

#Chimeric Antigen Receptor 4

#Chimeric antigen receptors (CARs) 8

#CHMP 2

#cholesterol 1

#chronic lymphocytic leukemia 1

#clinical review 1

#CLL 2

#CMet inhibitors 1

#cMet signaling pathway 1

#Colony-stimulating factors CSF 1

#colorectal cancer 1

#comparability 1

#complement factor C3 inhibitor 1

#Complement Mab Drug Discovery 1

#complement system 5

#complement-dependent cytolysis 2

#Complement-Mediated Diseases 1

#Complete Freund's Adjuvant (CFA) 1

#compstatin 1

#conditional approval 1

#conformations 1

#Cosentyx 1

#Crohn's disease 3

#CrossMAb technology 1

#CT-P13 1

#CTLA, cytotoxic T lymphocyte antigen 1

#CTLA4 20

#cutaneous T-cell lymphomas (CTCLs) 1

#CV events 1

#Cytokine fusion proteins 1

#cytokine immune activators 1

#cytokine-release syndrome 1

#cytokines 7

#Cytolytic fusion proteins 1

#Cytomegalovirus (CMV) 1

#Cytotoxic T Cell Specific Immunotherapy 1

#cytotoxic T lymphocyte 2

#cytotoxic T lymphocytes 4 2

#cytotoxic T-lymphocyte antigen-4 4

#dabrafenib 1

#daclizumab 2

#Dendritic cell vaccine 4

#Dendritic cells 5

#dendrtic cell vaccine 1

#dengue vaccine 1

#Dengue virus 1

#DNA vaccine 1

#Domain antibody 1

#Dr. James P. Allison 1

#drug delivery 1

#Drug Prices 1

#DVD-IgTM 1

#Ebola 1

#Ebola mab 1

#Ebola monoclonal antibody 2

#ebola outbreak 1

#Ebola therapy 1

#Ebola virus mabs 1

#EBV infected lymphoma cells 1

#EBV-CTLs 1

#EC approval 1

#eculizumab 1

#EGFR 1

#Ektomun® 1

#EMA 2

#EMA approval 5

#EMA biosimilar guidelines 2

#Enbrel 1

#Epstein-Barr virus (EBV) 1

#Erbitux 1

#ESMO 2014 1

#etanercept 1

#Evolocumab 1

#Eylea (aflibercept) 1

#Fast track priority approval 1

#FDA biosimilar guidelines 2

#FDA analysis 1

#FDA approval 5

#FDA fast track 1

#FDA fast track review 1

#FDA priority review 1

#FDA review 1

#fibrosis 1

#first biosimilar mab 1

#fluorescence-activated cell sorting 1

#foreign immunodominant peptide (GP33) 1

#Formula Pharma 1

#Fully Human mabs 1

#G protein-coupled receptors (GPCRs) 1

#Garvin Institute 1

#GD22 1

#GEN 1

#genetically modified T cells 1

#Genticel 1

#Global cancer market 2014 1

#glycoprotein B specific mab 2

#Glycoprotein H mab 1

#GM-CSF 1

#GMP 1

#golimumab 1

#GPCR mabs 1

#GVAX 1

#H1N1 strain 1

#HBV mab 1

#health insurance 1

#healthcare 1

#heaptocellular carcinoma HCC 1

#Hematologic Malignancies 1

#hepatitis B 1

#hepatocyte growth factor 1

#Heptares StaR® proteins 1

#Heptares Therapeutics 1

#HER-Vax 1

#HER2 2

#HER2+ve breast cancer 1

#Herceptin 1

#Herceptin® factory 1

#Herpes Simplex Virus 1

#high affinity antibody fragments 1

#high-affinity, PEGylated Fab 1

#histamine 1

#histidine rich protein2 (HRP2) 1

#HIV mab 2

#Holoclar 1

#HPLC 1

#HuMab 5B1 1

#human epidermal growth factor receptor 1

#human T cell leukaemia virus type-I 1

#Humaneered® mab 1

#humanized monoclonal antibody 1

#Humira 2

#Ibalizumab 1

#Igenica Biotherapeutics 1

#IgG 1

#IgG2 1

#IgG4 mab 1

#IL-17A 1

#IL-1α /IL-1β 1

#IL12 1

#IL17 inhibitors 2

#IL2 1

#IL2 receptor 1

#IL23 1

#IL23 pathway 2

#IL23A mab 2

#IL6 2

#IL7/15 1

#immune cells 1

#immune monitoring 1

#Immune Pharma 1

#immune response 3

#immune system 1

#Immune System Activation ISA 1

#immuno activation 1

#immuno-oncology 47

#immunoconjugates 1

#immunodominant CTL epitope 1

#immunostimulation 1

#immunostimulator 1

#immunosuppression 1

#immunotherapy 64

#immunotoxins 3

#improved biologics 1

#IMS Health 1

#Imugene 1

#inflammation 1

#inflammatory bowel disease 1

#infliximab 5

#Influenza 1

#influenza vaccine 1

#Innate immunity 2

#Innate Immunotherapeutics 1

#Innate Pharma 1

#Inotuzumab ozogamicin 1

#interferons 2

#interleukin 1

#Interleukin 15 ( IL15) 1

#Interleukin 17A 1

#interleukin 23 1

#interleukin 6 2

#interleukins 1

#Intracellular Antibody Capture IAC 1

#ipilimumab 6

#J&J 1

#JAMA Oncology 1

#JCO 1

#Johns Hopkins 1

#Journal for Immunotherapy of Cancer 2

#Juno therapeutics 1

#juvenile idiopathic arthritis 1

#Kadcyla 1

#KaloBios 1

#KB001-A 1

#Keystone Symposia 1

#Keytruda 2

#Kite pharma 1

#Kyowa Hakko Kirin 1

#LAG-3 2

#LAG-3 (CD223) 2

#LAG3 1

#lampalizumab 1

#LC/MS 1

#LDL cholesterol 1

#lempalizumab 1

#leukemia 1

#licensing deal 1

#ligands 1

#Lindis Biotech 1

#lipid lowering 2

#listeria vaccine 1

#Lucentis 2

#lung cancer 4

#Lymphoma 1

#M-CSF 1

#mab 1

#mAb mixtures 1

#mab specificity 1

#mabs 4

#MabVax 1

#macrodrug 1

#MacroGenics 1

#macrophage 1

#macular degeneration 1

#malaria diagnosis 1

#manufacture 1

#marketing rights 1

#mast cells 1

#MaxCyte 1

#mCRPC 1

#Medimmune 1

#Meditope Biosciences 1

#Melanoma 6

#melanoma immunotherapy 1

#melanoma review 1

#melanoma therapy 1

#melanoma vaccine 1

#Meningococcol B Vaccine 1

#Merck 2

#metastatic breast cancer 1

#metastatic melanoma 5

#microsomal vesicles 1

#Mogamulizumab 1

#monoclonal antibodies 3

#Monoclonal antibodies (mAbs) 53

#monoclonal antibody 13

#monocytes 1

#Monomeric Fc 1

#MTD, maximum tolerated dose 1

#Multidrug resistance (MDR) 1

#multitargeting 1

#multivalent antibodies 1

#Mylotarg® 1

#NanomAbs 1

#Natalizumab 1

#Nature 1

#Nature Medicine 1

#NCE/NME 1

#NEJM 3

#New Drug Approvals 1

#NHance™ 1

#NHL 1

#NIAID 1

#NIH 1

#NIST 1

#Nivolumab 6

#NK cell immunotherapy 1

#NK cells 11

#NKG2D ligand 1

#NKTm cells 1

#NOAEL, no observed adverse effect level 1

#Non Hodgkin Lymphoma NHL 1

#Non-Hodgkin Lymphoma 2

#Novartis 3

#NSCLC 6

#Nurimmune 1

#obinutuzumab 1

#ofatumumab 1

#OmniFlip 1

#OmniMouse 1

#OmniRat 1

#Oncobiologics 1

#oncology 2

#Oncology drug development 1

#Oncolytic immunotherapy 5

#oncolytic vaccines 2

#oncolytic viruses 3

#oncovaccine 9

#OncoVax 1

#Ono Pharma 1

#Opdivo 2

#Open Monoclonal Technology OMT 1

#OPN-305 1

#Opsona Therapeutics 1

#Orphan Drug Designation 1

#Ossianix 1

#Ossianix VNAR Phage Display Libraries 1

#Osteoarthritis OA 1

#ovarian cancer 1

#overall response rate ORR 1

#Overall survival 2

#OX40 2

#OX40 agonist 1

#Pamlico Biopharma 1

#pancreatic cancer 1

#Pandemic influenza 1

#paroxysmal nocturnal hemoglobinuria PNH 1

#PASI 1

#PASI 75 1

#PCSK9 inhibitors 2

#PD-1/PD-L1 24

#PD-L1 (B7-H1) immunohistochemistry IHC 1

#PD/PK 1

#PD1 1

#PD1 inhibitor 7

#PD1/PDL1 antagonists 2

#PDL1 1

#PDL1 biomarker 2

#PDL1 inhibitor 2

#PDL2 2

#Pediatric cancer 1

#PEGylation 1

#pembrolizumab 5

#peptide 1

#Peregrine Pharma 2

#Pfizer 1

#Phagocytosis 1

#Pharmaceutical Industry 1

#pharmacodynamics 2

#pharmacokinetics 2

#Phase 1 1

#Phase I 1

#Phase I starting dose 1

#Phase II 1

#Phase III data 2

#Philogen 1

#Phosphatidylserine-Recognizing Peptide 1

#Pidilizumab 2

#PK 1

#PK/PD 1

#PLoS One 3

#PLOS Pathogens 1

#Pneumococcal pneumonia 1

#poly(N-isopropylacrylamide) (PNiPAAm) 1

#polyclonal recombinant antibodies 1

#polymer micelles 1

#Polytherics 1

#positron emission tomography PET 1

#POTELLIGENT® 1

#Progenics Pharma 1

#programed cell death 5

#programmed cell death ligand 1 (PD-L1) 3

#protein-protein interactions 1

#PS mab 1

#Pseudomonas aeruginosa 1

#PSMA ADC 1

#psoriasis 5

#Psoriatic arthritis PsA 1

#R&D 1

#R&D collaboration 1

#R&D deal 1

#R&D pipeline 1

#ranibizumab 3

#receptor tyrosine kinase 1

#reference medicinal product 1

#Regeneron 1

#Remicade 3

#Remsima® (infliximab) 1

#Reuters 1

#Reverse Translational Medicine™ (RTM™) 1

#review 1

#Rheumatoid arthritis 1

#rheumatoid arthritis (RA) 3

#Rituxan 2

#Rituximab 4

#RNA CAR 1

#RNA immunotherapy 1

#RNA Vaccines 1

#Roactemra 2

#Roche 4

#Sanofi 4

#seasonal influenza 1

#secukinumab 1

#serogroup B meningococcal vaccine 1

#severe limbal stem cell deficiency LSCD 1

#Shire 1

#Side effects 1

#SIMPLE Antibody™ Platform 1

#Singapore 1

#single domain 1

#single photon emission computed tomogra 1

#SITC 2015 1

#skin immunology 1

#small cell lung cancer SCLC 1

#SnAP technology platform 1

#Solvanix 1

#Sonepcizumab 1

#SPECT 1

#StAbilize™ Technology 1

#stable antibodies 1

#state of the art review 1

#STC Biologics 1

#STD10, severely toxic dose in 10% 1

#stem cell therapy 1

#stem cell transplant 1

#stem cells 1

#Super Statins 1

#Symohogen 1

#systemic inflammatory response syndrome 1

#T cell activation 8

#T cell bispecific antibody 1

#T cell blockers 2

#T cell immunotherapy 2

#T cell leukemia/lymphoma 1

#T cell metabolism 1

#T cell Receptor 9

#T cell receptor signaling 3

#T cell regulation 2

#T cell tolerance 1

#T cell vaccines 1

#T cells 5

#T cells regulatory/T reg 2

#T reg 3

#T-cell immunoglobulin mucin domain TIM 1

#TaiMed Biologics 1

#targeted therapy 1

#TCR 1

#TCR signaling 2

#TG 4010 1

#Th2 1

#The Society for Immunotherapy of Cancer 1

#Therapeutic Antibodies 3

#Therapeutic antibody 1

#therapeutic mabs 3

#therapy 1

#ThioBridge™ 1

#TIL 1

#tildrakizumab 2

#TILs 1

#TIM-3 2

#TLR 1

#TLR mab 1

#TLR8 1

#TNF 2

#TNF inhibitors 4

#TNF superfamily 4

#TNFRSF25 agonistic mab 1

#Tocilizumab 3

#toll like receptor 1

#Top 10 drugs 1

#top 10 mabs 2

#top 10 ranking table 1

#top selling human medicine 2

#toxicology studies 1

#Transgene 1

#trastuzumab 2

#tregalizumab 1

#tremelimumab 1

#TrendAbs 1

#TrispecificAbs 1

#True Human™ monoclonal antibodies 2

#True North Therapeutics 1

#Trumenba 1

#tumor antigens 4

#tumor immunology 4

#tumor infilterating lymphocytes TILs 2

#tumor infiltrating lymphocytes 4

#tumor microenvironment 3

#Tumor necrosis factor alfa 1

#tumor-associated carbohydrate antigen 1

#Tumor-infiltrating Lymphocytes 1

#Ulcerative colitis 2

#University South Florida 1

#Unum Therapeutics 1

#UPENN 1

#vaccine technology 1

#vaccines 3

#Vaccinogen 1

#vascular disease 1

#Vaxiclase 1

#vemurafenib 1

#VentiRx Pharma 1

#VNAR shark antibodies 1

#vvemurafenib 1

#Vγ9Vδ2 T cell 1

#Webinar 1

#WuXi PharmTech. 1

#XBiotech 2

#Xilonix™ 1

#YaleCancer 1

229E 1

AAV-based 1

adc 72

adjuvant 1

adoptive T-cell 1

adverse 1

antibodies 1

antibody 1

Antibody response 1

anticorps 1

article scientifique 3

autoimmmune 1

autoimmune disease 1

autoimmunity 1

awareness 1

Belgium 1

biologics 1

biopharma 1

biotech 2

bovine 1

broken link 3

cancer 8

CAR T cell 2

CAR-T 1

cardiology 1

cartoons 1

casirivimab 1

CD4 3

células dendríticas 1

Cindy 1

Clinical trial 2

clinical trials 1

Cocvid-19 1

complement 1

coronavirus 2

correlate 1

correlate of protection 1

Council of Europe 1

covid-19 50

Cows 1

curation 1

Current opinion in Immunology 1

Cypress 1

cytokines 1

DCs 1

dendritic cells 1

dengue 1

development 1

diabetes 1

Drug Costs 1

EMA 1

European 1

evolution 1

FDA 1

gene editing 2

gene therapy 1

genome editing 2

Global 1

Global health 1

GPCR 1

graphics 1

graves' 1

HCoV 1

healthcare social media 1

hematology 11

herpes 1

herpes labialis 1

HSV-1 1

IDSA 1

imdevimab 1

immune response 1

immunité sociale 1

immunology 2

Immunotherapy 4

immunotoxins 1

impact 1

Infections 1

influenza 1

interactive 1

JAK 1

Janssen 1

Journal 1

lens.org 1

llama antibodies 1

LNP 1

Low IL-2 in lupus therapy 1

lung cancer 1

lymphome 1

Malaria 1

medical 2

medicine 1

meganuclease 1

melanoma 2

mRNA 1

mRNA therapy 1

MSC 1

mucosal 1

nanobody 1

nanopaticle 1

nanovaccines 1

natural killer 1

neutralization 1

oncology 1

organ donation day 1

organ donors 1

outcomes 1

ovarian cancer 1

patents 1

phage 1

phage therapy 1

phase I 1

Protein-protein-interactions 1

psoriasis 1

real-time 1

Recovery trial 1

Regeneron 1

Registry 1

REpurposing 1

research 2

research articles 1

review article 2

rotavirus 1

RSV 1

SAb Therapeutics 1

SARS-CoV-2 3

side effects 1

side effetcs 1

smoking 1

solid tumor 1

stem cells 1

T cells 2

therapeutic antibody 1

Therapy 1

topical 1

traitement 1

transplant recipients 1

Type I diabetes mellitus (T1DM) 1

vaccin 2

vaccination 2

vaccine 10

Vaccine efficacy 1

Vaccines 3

vaccinology 16

VHH 1

video 1

videos 1

virus 1

visual 1

vitellogenin 1

VP6 1

YouTube 1

Immunology and Biotherapies

Page Ressources et Actualités du DIU immunologie et biothérapies

Curated by Gilbert C FAURE

Your new post is loading...

Scooped by Gilbert C FAURE

Scoop.it!

From cancerkick.com - July 19, 2012 11:53 AM

No comment yet.

Scooped by Gilbert C FAURE

Scoop.it!

From physicsinventions.com - July 18, 2012 10:48 AM

No comment yet.

Scooped by Marcelo de Carvalho Bittencourt

Scoop.it!

From www.ncbi.nlm.nih.gov (via @bodbrain) - July 18, 2012 10:31 AM

No comment yet.

Scooped by Gilbert C FAURE

Scoop.it!

From trialx.com - July 18, 2012 9:44 AM

No comment yet.

Scooped by Gilbert C FAURE

Scoop.it!

From cancerkick.com - July 18, 2012 9:40 AM

No comment yet.

Scooped by Gilbert C FAURE

Scoop.it!

From www.currentpartnering.com - July 17, 2012 9:57 AM

No comment yet.

Scooped by Gilbert C FAURE

Scoop.it!

From www.sys-con.com - July 17, 2012 9:55 AM

No comment yet.

Scooped by Gilbert C FAURE

Scoop.it!

From www.ncbi.nlm.nih.gov (via @Dr_Wareing) - July 17, 2012 9:53 AM

No comment yet.

Scooped by Gilbert C FAURE

Scoop.it!

From www.twease.org - July 16, 2012 7:48 AM

No comment yet.

Scooped by Gilbert C FAURE

Scoop.it!

From arthritis-research.com - July 16, 2012 6:49 AM

No comment yet.

Scooped by Gilbert C FAURE

Scoop.it!

From pharmabiz.com (via @Harit1) - July 15, 2012 1:46 PM

No comment yet.

Scooped by Gilbert C FAURE

Scoop.it!

From www.marketwatch.com - July 14, 2012 3:41 AM

No comment yet.

Scooped by Gilbert C FAURE

Scoop.it!

Gastroenterology News - Long-term outcome of a third anti-TNF monoclonal antibody after the failure of two prior anti-TNFs in inflammatory bowel disease |4137253 | Immunology and Biotherapies | Scoop.it

From www.mdlinx.com (via @MDLinx) - July 14, 2012 3:39 AM

No comment yet.

Scooped by Gilbert C FAURE

Scoop.it!

From blogs.terrapinn.com - July 18, 2012 1:17 PM

No comment yet.

Scooped by Gilbert C FAURE

Scoop.it!

From nanopatentsandinnovations.blogspot.fr - July 18, 2012 10:48 AM

No comment yet.

Scooped by Marcelo de Carvalho Bittencourt

Scoop.it!

From www.omicsgroup.org (via @OMICSGroup) - July 18, 2012 10:28 AM

No comment yet.

Scooped by Gilbert C FAURE

Scoop.it!

From www.stemcellmedicine.tv - July 18, 2012 9:41 AM

No comment yet.

Scooped by Gilbert C FAURE

Scoop.it!

From cgd.swissre.com - July 17, 2012 1:12 PM

No comment yet.

Scooped by Gilbert C FAURE

Scoop.it!

From www.thegavoice.com - July 17, 2012 9:55 AM

No comment yet.

Scooped by Gilbert C FAURE

Scoop.it!

Actinium Pharmaceuticals, Inc. Licenses Monoclonal Antibody From Fred Hutchinson Cancer Research Center - HispanicBusiness.com | Immunology and Biotherapies | Scoop.it

From www.hispanicbusiness.com (via @PatientSafety01) - July 17, 2012 9:53 AM

No comment yet.

Rescooped by Gilbert C FAURE from Immunology

Scoop.it!

From www.asianscientist.com - July 16, 2012 8:04 AM

No comment yet.

Scooped by Gilbert C FAURE

Scoop.it!

From defeatosteosarcoma.org - July 16, 2012 6:50 AM

No comment yet.

Scooped by Gilbert C FAURE

Scoop.it!

From www.translational-medicine.com - July 16, 2012 6:41 AM

No comment yet.

Scooped by Gilbert C FAURE

Scoop.it!

From www.futuremedicine.com (via @IgECPD4) - July 15, 2012 1:45 PM

No comment yet.

Scooped by Gilbert C FAURE

Scoop.it!

From www.sciencedaily.com - July 14, 2012 3:41 AM

No comment yet.

Immunology and Biotherapies

Actinium Pharmaceuticals Successfully Completes First Cohort in ...

Stem Cells Repair Damaged Spinal Cord Tissue - Physics Inventions

Innovating immunology: an interview with Ruslan Medzhitov

Elotuzumab, CS1 Directed Antibody Therapy For Multiple Myeloma: Clinical Trial Results

Cytomedix Announces Collaboration With Duke University on Phase ...

Janssen Biotech and Genmab collaborate for antibody development ...

Scientists from Singapore Immunological Network Discover Dendritic Cells Key ... - SYS-CON Media (press release)

Anti-HLA antibodies in Regenerative Medicine Ste... [Hum Immunol. 2012] - PubMed - NCBI

The World Market for Cancer Therapeutics and Biotherapeutics ...

Arthritis Research & Therapy | Full text | Quantiferon-TB Gold in tube ...

Actinium Pharma gets rights to develop & commercialize BC8 monoclonal antibody from FHCRC

Immunovaccine's DPX-Survivac Featured in Presentation at Federation of ... - MarketWatch (press release)

Gastroenterology News - Long-term outcome of a third anti-TNF monoclonal antibody after the failure of two prior anti-TNFs in inflammatory bowel disease |4137253

Antibody development in the next 5 years

Nano Patents and Innovations: Nanoscale Scaffolds And Stem Cells ...

OMICS - BLOG | Dirty' Wild Mice May Be More Relevant Immunology Model » OMICS - BLOG

NeoStem's Subsidiary, Progenitor Cell Therapy, and SOTIO Enter ...

Swiss Biotech Roundtable: next-generation antibodies | Swiss Re - Centre for Global Dialogue

Emory Vaccine Centers gets $7 million boost for HIV fight - The GA Voice

Actinium Pharmaceuticals, Inc. Licenses Monoclonal Antibody From Fred Hutchinson Cancer Research Center - HispanicBusiness.com

Chugai Pharma Opens $200m Antibody Lab In Singapore

Cancer and Innate Immune System Interactions: Translational ...

JTM | Full text | Defining the Critical Hurdles in Cancer Immunotherapy

Combating chronic T-cell exhaustion, Immunotherapy, Future Medicine

Immunology: Vaccine Hope for Virile Virus - Science Daily (press release)